None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients were eligible to enter the study if they were 18 years of age or older, American Society of Anesthesiology (ASA) risk class I, II or III, and scheduled for ERCP only.
Exclusion criteria
Exclusion criteria: Exclusion criteria were as follows: (1) acute pancreatitis during the 2 weeks before ERCP; (2) a history of chronic pancreatitis; (3) non-naïve major papilla such as previous sphincterotomy, pancreatic sphincterotomy or balloon dilatation; (4) the major papilla could not be reached becaused of anatomical or surgical alteration (total gastrectomy with Roux en Y anastomosis, choledocho-jejunostomy or hepatico-jejunostomy); (5) a 1.5-fold or more hyperamylasemia at 4 hours after ERCP; (6) immediately bleeding, perforation, suspected cholecystitis or cholangitis within 4 hours after ERCP; (7) refusal to participate in the study or declining to provide informed consent. Patients with a confirmed pregnancy and those who were breastfeeding were also excluded. Finally, patients were excluded if they underwent ERCP on an outpatient basis, for procedures such as stone removal following previous sphincterotomy, change or removal of previous plastic biliary stents, or surveillance biopsy after endoscopic papillectomy without pancreatocholangiography, which are considered to carry minimal potential risks of PEP.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence of post ERCP pancreatitis | — |
Secondary
| Measure | Time frame |
|---|---|
| the length of hospitalization;the medical expenses for ERCP treatment;the diagnostic accuracy for prediction of PEP based on amylase levels 4 hours after ERCP | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center-Dongtan